EDAP TMS (FOCL)
NASDAQ:FOCL
Want to see FOCL full AI Analyst Report?
FOCL Stock Chart & Stats
$3.49
-$0.15(-5.88%)
At close: 4:00 PM EST
$3.49
-$0.15(-5.88%)
Day’s Range― - ―
52-Week Range$1.21 - $5.05
Previous CloseN/A
VolumeN/A
Average Volume (3M)36.57K
Market Cap
$174.29M
Enterprise Value$149.26M
Total Cash (Recent Filing)$15.01M
Total Debt (Recent Filing)$2.35M
Price to Earnings (P/E)―
Beta1.03
Next Earnings
Aug 26, 2026EPS Estimate
-0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.77
Shares Outstanding37,481,987
10 Day Avg. Volume28,395
30 Day Avg. Volume36,573
Financial Highlights & Ratios
PEG Ratio-0.08
Price to Book (P/B)6.35
Price to Sales (P/S)1.74
P/FCF Ratio-5.56
Enterprise Value/Market Cap0.86
Enterprise Value/Revenue2.07
Enterprise Value/Gross Profit4.77
Enterprise Value/Ebitda-6.38
Forecast
1Y Price Target
$10.00Price Target Upside186.53% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.88
Revenue Forecast (FY)$67.19M
Bulls Say, Bears Say
Bulls Say
Commercial AdoptionRecord placements of the Focal One HIFU system and standardization across major health systems support accelerating commercial adoption and higher procedure volumes.
Reimbursement PolicyHigher Medicare reimbursement for the Focal One procedure creates a clearer financial incentive for hospitals and physicians to adopt the technology and boost utilization.
Revenue GuidanceManagement issued revenue guidance above market consensus, signaling confidence in continued topline expansion driven by the HIFU business.
Bears Say
Currency VolatilityCurrency fluctuations present a risk to reported revenue and earnings for the company given its international exposure.
Margin PressureGross margin faces pressure from tariffs and an inventory reserve related to legacy parts, which could weigh on near-term profitability.
Regulatory And Intellectual Property RiskRegulatory hurdles and potential intellectual property disputes could delay commercialization in key markets or increase legal and compliance costs.
FOCL FAQ
What was EDAP TMS’s price range in the past 12 months?
EDAP TMS lowest stock price was $1.21 and its highest was $5.05 in the past 12 months.
What is EDAP TMS’s market cap?
EDAP TMS’s market cap is $174.29M.
When is EDAP TMS’s upcoming earnings report date?
EDAP TMS’s upcoming earnings report date is Aug 26, 2026 which is in 82 days.
How were EDAP TMS’s earnings last quarter?
Currently, no data Available
Is EDAP TMS overvalued?
According to Wall Street analysts EDAP TMS’s price is currently Undervalued.
Does EDAP TMS pay dividends?
EDAP TMS does not currently pay dividends.
What is EDAP TMS’s EPS estimate?
EDAP TMS’s EPS estimate is -0.23.
How many shares outstanding does EDAP TMS have?
EDAP TMS has 37,481,987 shares outstanding.
What happened to EDAP TMS’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of EDAP TMS?
Currently, no hedge funds are holding shares in FOCL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
EDAP TMS Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (186.53% Upside)
$10.00 (186.53% Upside)
Blogger Sentiment
Bullish
FOCL Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth $42.2K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
152.89%
12-Months-Change
Fundamentals
Return on Equity
-148.90%
Trailing 12-Months
Asset Growth
-11.03%
Trailing 12-Months
Company Description
EDAP TMS
EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.
FOCL Stock 12 Month Forecast
Average Price Target
$10.00
▲(186.53% Upside)
Technical Analysis
Ownership Overview
2.71% Insiders
1.17% Mutual Funds
28.38% Other Institutional Investors
67.75% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---